✦ LIBER ✦

PAO1 CARDIORENAL EFFECTS AND COSTS OF COX-2 INHIBITORS IN A MANAGED CARE ORGANIZATION

✍ Scribed by KS Yu-Isenberg; RS Leslie; EY Chang; TJ White; KL Bailey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAO19 UTILIZATION CHARACTERISTICS OF COX

✍ W Yu; G Kiang; LR Etemad 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PGI11 RETROSPECTIVE ANALYSIS OF A PRIOR

✍ A Barlev; W Yu; K Johnson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

PAO1: COST-EFFECTIVENESS ANALYSIS OF NSA

✍ HR Yun; M Corzillius; SY Kim; SC Bae 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Effect of cylcoxygenase (COX)-2 specific

✍ D.V Pettitt; G Singh; J.S Schwartz; J.L Goldstein 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 28 KB

PHV30: COSTS AND OUTCOMES OF A RESPIRATO

✍ M Schaffer; MA Amaya; D Vojta 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

The excess costs of breast cancer health

✍ Kristine Tollestrup; Floyd J. Frost; Christine A. Stidley; Edward Bedrick; Garne 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 48 KB